Ankar Pharma S.L.

Spin-off of CSIC we have the exclusive IP rights to develop Ap-1 for Multiple Sclerosis. 2 Mill€ invested -additional 2 Mill€ to license to a pharma company.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Madrid, Spain
  • Currency EUR
  • Founded 2014
  • Employees 3
  • Incorporation Type LLC
  • Website ankarpharma.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free